Ping‐sheng Wu

457 total citations
28 papers, 363 citations indexed

About

Ping‐sheng Wu is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Ping‐sheng Wu has authored 28 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Ping‐sheng Wu's work include Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (6 papers) and Hormonal Regulation and Hypertension (5 papers). Ping‐sheng Wu is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (6 papers) and Hormonal Regulation and Hypertension (5 papers). Ping‐sheng Wu collaborates with scholars based in China, Australia and Japan. Ping‐sheng Wu's co-authors include Ying Meng, Zhen‐shu Zhang, Xu Li, Bing Xiao, Qiang Ma, Ying Shen, Xu Li, Jiping Zhang, Wenyan Lai and Zhenhong Zhang and has published in prestigious journals such as Cardiovascular Research, Pharmacological Research and Journal of the American Heart Association.

In The Last Decade

Ping‐sheng Wu

28 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ping‐sheng Wu China	11	92	89	82	66	61	28	363
Julia Leonhardt Germany	7	147 1.6×	102 1.1×	70 0.9×	34 0.5×	49 0.8×	8	316
Sulin Zheng China	9	116 1.3×	96 1.1×	100 1.2×	37 0.6×	143 2.3×	13	361
Regina Maria Pereira Brazil	10	262 2.8×	106 1.2×	168 2.0×	112 1.7×	121 2.0×	12	561
L. Sepassi United States	5	84 0.9×	93 1.0×	69 0.8×	53 0.8×	45 0.7×	5	380
Özgür Mehmet Yis Türkiye	11	34 0.4×	82 0.9×	41 0.5×	62 0.9×	61 1.0×	26	425
Maria Margherita Rando Italy	12	42 0.5×	113 1.3×	62 0.8×	125 1.9×	113 1.9×	30	415
Amos Lanir Israel	14	53 0.6×	96 1.1×	15 0.2×	78 1.2×	66 1.1×	19	541
Le Sun China	12	97 1.1×	79 0.9×	74 0.9×	88 1.3×	147 2.4×	35	505
Elvira Arrizurieta Argentina	15	75 0.8×	186 2.1×	80 1.0×	51 0.8×	29 0.5×	47	499
Lars Gullestad Norway	8	166 1.8×	72 0.8×	41 0.5×	71 1.1×	50 0.8×	14	330

Countries citing papers authored by Ping‐sheng Wu

Since Specialization

Citations

This map shows the geographic impact of Ping‐sheng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping‐sheng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping‐sheng Wu more than expected).

Fields of papers citing papers by Ping‐sheng Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping‐sheng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping‐sheng Wu. The network helps show where Ping‐sheng Wu may publish in the future.

Co-authorship network of co-authors of Ping‐sheng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Ping‐sheng Wu. A scholar is included among the top collaborators of Ping‐sheng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping‐sheng Wu. Ping‐sheng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Shenghui, Cheng Liu, Ping‐sheng Wu, et al.. (2024). Burden and Temporal Trends of Valvular Heart Disease‐Related Heart Failure From 1990 to 2019 and Projection Up to 2030 in Group of 20 Countries: An Analysis for the Global Burden of Disease Study 2019. Journal of the American Heart Association. 13(20). e036462–e036462. 3 indexed citations

Li, Mingyan, et al.. (2018). Effects of Triple-Mutated Hypoxia-Inducible Factor-1α on Angiogenesis and Cardiac Function Improvement in Rats with Myocardial Infarction. Cellular Physiology and Biochemistry. 50(6). 2329–2340. 10 indexed citations

Zhang, Zhenhong, et al.. (2016). The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: A meta-analysis. Pharmacological Research. 105. 74–83. 38 indexed citations

Chen, Zhujun, et al.. (2015). Blood pH in coronary artery microthrombosis of rats. Asian Pacific Journal of Tropical Medicine. 8(10). 864–869. 7 indexed citations

Wu, Ping‐sheng, et al.. (2014). All-cause mortality and cardiovascular events with nicorandil in patients with IHD: Systematic review and meta-analysis of the literature. International Journal of Cardiology. 176(3). 661–669. 14 indexed citations

Chen, Zhujun, et al.. (2014). Apoptosis and calcification of vascular endothelial cell under hyperhomocysteinemia. Medical Oncology. 32(1). 403–403. 18 indexed citations

Chen, Dongdong, Yulin Liao, Qiulin Xu, et al.. (2012). Persistence of systolic and diastolic regional dysfunction after brief episodes of myocardial ischemia evaluated with velocity vector imaging. International Journal of Cardiology. 167(3). 987–994. 6 indexed citations

Xie, Jiajia, Yulin Liao, Li Yang, et al.. (2011). Ultrasound molecular imaging of angiogenesis induced by mutant forms of hypoxia-inducible factor-1α. Cardiovascular Research. 92(2). 256–266. 10 indexed citations

Li, Mingyan, Cheng Liu, Jianping Bin, et al.. (2010). Mutant hypoxia inducible factor-1α improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle. Microvascular Research. 81(1). 26–33. 17 indexed citations

10.

Li, Xu, Ying Meng, Bing Xiao, et al.. (2009). Upregulation of angiotensin‐converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors. Clinical and Experimental Pharmacology and Physiology. 37(1). e1–6. 74 indexed citations

11.

Li, Xu, et al.. (2006). Angiotensin II and Aldosterone stimulating NF-κB and AP-1 activation in hepatic fibrosis of rat. Regulatory Peptides. 138(1). 15–25. 54 indexed citations

12.

Li, Xu, et al.. (2005). [Aldosterone stimulating PDGF-B expression in HSC via activation of EGR-1].. PubMed. 13(8). 567–70. 4 indexed citations

13.

Liu, Yili, et al.. (2005). [An experimental study on renal microvascular perfusion in dogs with acute cardiac insufficiency].. PubMed. 33(7). 643–7. 1 indexed citations

14.

Li, Xu, et al.. (2004). [Perindopril attenuates the progression of CCl4-inducing rat hepatic fibrosis].. PubMed. 12(1). 32–4. 4 indexed citations

15.

Zhang, Yijun, Ping‐sheng Wu, Xu Li, et al.. (2003). Effects of angiotensin II and losartan on the growth and proliferation of hepatic stellate cells.. PubMed. 23(3). 219–21, 227. 4 indexed citations

16.

Zhang, Yijun, et al.. (2003). Expression of Angiotensin II Type 1 Receptor in Rat Hepatic Stellate Cells and Its Effects on Cell Growth and Collagen Production. Hormone Research in Paediatrics. 60(3). 105–110. 9 indexed citations

17.

Wu, Ping‐sheng, et al.. (2003). [Construction and expression analysis of recombinant vector pcDNA3.1+-HIF-1alpha].. PubMed. 23(11). 1134–6. 1 indexed citations

18.

Liu, Yili, et al.. (2002). [Cloning of expression vector for VEGF121 and VEGF165 genes encoding human vascular endothelial growth factor].. PubMed. 22(2). 111–3. 1 indexed citations

19.

Wu, Ping‐sheng, et al.. (1999). Effects of cholic acid on blood pressure and production of vascular aldosterone and corticosterone. Steroids. 64(4). 291–295. 12 indexed citations

20.

Wu, Ping‐sheng, Zhigang Guo, Yili Liu, et al.. (1998). Aldosterone Overproduction and CYP11B2 mRNA Overexpression in Vessels of Spontaneously Hypertensive Rats. Hormone Research in Paediatrics. 50(1). 28–31. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact